Company Filing History:
Years Active: 2019-2024
Title: Chris Ho: Innovator in Pharmaceutical Compositions
Introduction
Chris Ho is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on innovative compositions and formulations that aim to improve treatment options for various diseases.
Latest Patents
Among his latest patents, one includes pharmaceutical compositions comprising venglustat. This patent relates to dosage forms, such as tablets or capsules, that include venglustat in its free base or pharmaceutically acceptable salt form. The composition also contains a diluent/filler and a lubricant, and it may be combined with additional therapeutic agents for enhanced efficacy.
Another significant patent involves pharmaceutical formulations of tropomyosin-related kinase (TRK) inhibitors. This formulation features a specific TRK inhibitor in microcrystalline suspension formulations, which demonstrates improved characteristics over its anhydrate form. Additionally, it includes extended-release formulations that utilize microspheres loaded with the TRK inhibitor, providing a more effective delivery method.
Career Highlights
Chris Ho is currently employed at Genzyme Corporation, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug formulations that are crucial for patient care and treatment efficacy.
Collaborations
Throughout his career, Chris has collaborated with notable colleagues, including Harvey Lieberman and Donglai Yang. These partnerships have fostered a collaborative environment that enhances the development of innovative pharmaceutical solutions.
Conclusion
Chris Ho's contributions to pharmaceutical compositions and formulations highlight his role as a key innovator in the industry. His patents reflect a commitment to improving therapeutic options for patients, showcasing the importance of innovation in healthcare.